Kevin H. Mayo
Department of Biochemistry
6-155 Jackson Hall
University of Minnesota Health Sciences Center
Minneapolis
USA
Name/email consistency: medium
- The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Dings, R.P., Yokoyama, Y., Ramakrishnan, S., Griffioen, A.W., Mayo, K.H. Cancer Res. (2003)
- Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity. Mayo, K.H., Dings, R.P., Flader, C., Nesmelova, I., Hargittai, B., van der Schaft, D.W., van Eijk, L.I., Walek, D., Haseman, J., Hoye, T.R., Griffioen, A.W. J. Biol. Chem. (2003)
- Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells. Mayo, K.H., van der Schaft, D.W., Griffioen, A.W. Angiogenesis (2001)
- Recent advances in the design and construction of synthetic peptides: for the love of basics or just for the technology of it. Mayo, K.H. Trends Biotechnol. (2000)